The drugmaker must produce the initial results of a randomized controlled trial of a second course of the antiviral by Sep. 30 next year, the FDA told Pfizer in a letter dated Aug. 5.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/RLT6O4s
I appreciate the informative post! I found something similar to us fda and thought you might be interested. Please check it out and let me know what you think!
ReplyDeletePost a Comment